16:11:00 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Coastal Contacts Inc (2)
Symbol COA
Shares Issued 32,830,881
Close 2014-04-22 C$ 12.43
Market Cap C$ 408,087,851
Recent Sedar Documents

Coastal Contacts receives court OK for Essilor deal

2014-04-23 16:47 ET - News Release

Mr. Terry Vanderkruyk reports

COASTAL.COM RECEIVES FINAL COURT APPROVAL FOR ACQUISITION BY ESSILOR INTERNATIONAL

The B.C. Supreme Court has issued a final order approving the statutory plan of arrangement under which Essilor International (Compagnie Generale d'Optique) S.A. will indirectly acquire all of the issued and outstanding common shares of Coastal.com for a purchase price of $12.45 per share.

The transaction was approved by approximately 100 per cent of the votes cast by Coastal.com's shareholders, including by approximately 100 per cent of the votes cast by shareholders excluding the votes attached to shares owned by certain executive officers as required under applicable securities laws, at an annual general and special meeting held on April 16, 2014. Subject to receipt of Competition Act approval and the satisfaction or waiver of customary closing conditions, the transaction is expected to close by the end of April, 2014.

About Essilor

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lens to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lens that meet his or her unique vision requirements. To support this mission, the company allocates more than 150 million euros to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilor's flagship brands are Varilux, Crizal, Definity, Xperio, Optifog, Foster Grant, Bolon and Costa. It also develops and markets equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of over five billion euros in 2013 and employs more than 55,000 people. It operates in about 100 countries with 28 plants, more than 450 prescription laboratories and edging facilities, as well as several research and development centres around the world. For more information, please visit the Essilor website.

The Essilor shares trade on the NYSE Euronext Paris market and are included in the Euro Stoxx 50 and CAC 40 indices.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.